Sulfated glycoprotein-2: an emerging molecular marker for neurodegeneration.
Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285.
P C
PC
May
D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D000818:Animals; D015415:Biomarkers; D001921:Brain / Q000378:metabolism*; D001930:Brain Injuries / Q000378:metabolism* / Q000473:pathology; D051152:Clusterin; D015870:Gene Expression; D006023:Glycoproteins / Q000032:analysis / Q000096:biosynthesis*; D006624:Hippocampus / Q000378:metabolism; D006801:Humans; D015151:Immunoblotting; D018832:Molecular Chaperones; D009410:Nerve Degeneration; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*
D015415:Biomarkers; C495242:CLU protein, human; D051152:Clusterin; D006023:Glycoproteins; D018832:Molecular Chaperones; D009419:Nerve Tissue Proteins